Fatty (change of) liver, not elsewhere classified Clinical Trials

24 clinical trials for Fatty (change of) liver, not elsewhere classified across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Liver microbiota axis at the center of healthy aging — RECRUITING
• Digitalization project: Identification of cardiovascular risk patients and detection of advanced liver fibrosis in patients with type-2-diabetes using non-invasive scores in outpatient care in Hessen — RECRUITING
• The Influence of Prolonged Therapeutic Fasting on Diabetic Fatty Liver and Muscle Build-up - an Exploratory Randomized Clinical Trial — RECRUITING
• Development of an NMR spectroscopy-based screening method for evaluating lipid profiles in serum and metabolites in urine to assess cardiovascular risk and enable early detection of type 2 diabetes in MASLD patients — RECRUITING
• HEPAfit-Study - Study on the use of pre- and probiotic foods and dietary supplements in the context of medically supervised weight loss programs — RECRUITING
• Chronotype Profiling in Patients with Non-Alcoholic Fatty Liver Disease — RECRUITING
• Effects of liver fat metabolism disorders on brain health using artificial intelligence — RECRUITING
• Prospective pilotstudy for the development and evaluation of softwaretools for non-invasive assessment of fibrosis and steatosis of the liver with machine learning methods — RECRUITING
• HepaLipa-Study: Observing the influence of an IL-17 inhibition on liver steatosis and inflammation. — RECRUITING
• Cross-sectional study on the prevalence of hepatic steatosis and fibrosis in patients undergoing assessment of sleep apnea — RECRUITING
• German SLD-Registry - Characterization of Patients With Steatotic Liver Disease (SLD) in Germany - Phase 1 (Observation of the Natural Course) — OTHER
• Characterization of the effects of one month of moderate consumption of various non-alcoholic beer beverages on liver fatty degeneration and metabolism — OTHER
• Effect of dietary lipid modification on nonalcoholic fatty liver disease in carriers of the PNPLA3 I148M genetic variant: an open label trial — OTHER
• Non Alcoholic Fatty Liver Disease (NAFLD) and Small Intestinal Bacterial Overgrowth (SIBO) — OTHER
• Sarcopenia, anabolic and catabolic hormones in liver cirrhosis (SACL) — OTHER
• Epidemiological evaluation of different biological markers for the classification of non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH) in obese participants with or without Type 2 diabetes — OTHER
• A randomised, placebo-controlled, single blind, monocentric trial to investigate the influence of an artichoke leaf extract for the treatment of non-alcoholic fatty liver disease (NAFLD) — OTHER
• Prospective evaluation of NAFLD patients with diabetes mellitus type 2 using transient elastography — OTHER
• Εvaluation of attenuation imaging (ATI) to elicit the degree of steatosis and shear wave dispersion mode (SWD) to quantify viscoelasticity in nonalcoholic steatohepatitis (NASH). — NOT_YET_RECRUITING
• Quality of life in patients with nonalcoholic fatty liver disease — OTHER
• Evaluation of feasibility and applicability of current EASL-EASD-EASO and DGVS guidelines for diagnosis of Non-Alcoholic Fatty Liver disease in Patients with Type 2 Diabetes mellitus. — OTHER
• Compared Investigation of inflammation and hyperglycemia associated molecular Signalling in Human Tissues (Patients with Sepsis, Diabetes mellitus type 2 and Metabolic Syndrome) — OTHER
• Studies on the gastrointestinal hormone fibroblast growth factor 19 (FGF19) in overweight and obese patients with non-alcoholic fatty liver diseases (NAFLD) — OTHER
• Vitamin D supplementation in patients with fatty liver and vitamin D deficiency — OTHER

Refine this search